A 2-year multicenter, double-blind, randomized, placebo-controlled study of bezafibrate for the treatment of primary biliary cholangitis in patients with inadequate biochemical response to ursodeoxycholic acid therapy (Bezurso)
(1)
,
(1)
,
(2, 3)
,
(4, 5)
,
(6)
,
(7)
,
(8)
,
(9)
,
(10)
,
(11, 12)
,
(13, 14)
,
(15)
,
(16, 17)
,
(18)
,
(19, 20)
,
(21, 22)
,
(23)
,
(24)
,
(25, 26)
,
(27)
,
(28, 29)
,
(30)
,
(31)
,
(1)
,
(3)
,
(1)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31